PMID- 36294662 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20221030 IS - 2309-608X (Electronic) IS - 2309-608X (Linking) VI - 8 IP - 10 DP - 2022 Oct 18 TI - Paracoccidioidomycosis: What We Know and What Is New in Epidemiology, Diagnosis, and Treatment. LID - 10.3390/jof8101098 [doi] LID - 1098 AB - Paracoccidioidomycosis (PCM) is a systemic mycosis endemic to Latin America caused by thermodimorphic fungi of the genus Paracoccidioides. In the last two decades, enhanced understanding of the phylogenetic species concept and molecular variations has led to changes in this genus' taxonomic classification. Although the impact of the new species on clinical presentation and treatment remains unclear, they can influence diagnosis when serological methods are employed. Further, although the infection is usually acquired in rural areas, the symptoms may manifest years or decades later when the patient might be living in the city or even in another country outside the endemic region. Brazil accounts for 80% of PCM cases worldwide, and its incidence is rising in the northern part of the country (Amazon region), owing to new settlements and deforestation, whereas it is decreasing in the south, owing to agriculture mechanization and urbanization. Clusters of the acute/subacute form are also emerging in areas with major human intervention and climate change. Advances in diagnostic methods (molecular and immunological techniques and biomarkers) remain scarce, and even the reference center's diagnostics are based mainly on direct microscopic examination. Classical imaging findings in the lungs include interstitial bilateral infiltrates, and eventually, enlargement or calcification of adrenals and intraparenchymal central nervous system lesions are also present. Besides itraconazole, cotrimoxazole, and amphotericin B, new azoles may be an alternative when the previous ones are not tolerated, although few studies have investigated their use in treating PCM. FAU - Pecanha, Paulo Mendes AU - Pecanha PM AUID- ORCID: 0000-0003-1387-5554 AD - Department of Medical Clinic, Division of Infectious Diseases, Federal University of Espirito Santo (UFES), Vitoria 29043900, Brazil. FAU - Pecanha-Pietrobom, Paula Massaroni AU - Pecanha-Pietrobom PM AD - Department of Medicine, Division of Infectious Diseases, Federal University of Sao Paulo (UNIFESP), Sao Paulo 04039032, Brazil. FAU - Grao-Velloso, Tania Regina AU - Grao-Velloso TR AD - Department of Dental Clinic, Federal University of Espirito Santo (UFES), Vitoria 29043900, Brazil. FAU - Rosa Junior, Marcos AU - Rosa Junior M AUID- ORCID: 0000-0001-8668-2804 AD - Department of Medical Clinic, Federal University of Espirito Santo (UFES), Vitoria 29043900, Brazil. FAU - Falqueto, Aloisio AU - Falqueto A AD - Department of Medical Clinic, Division of Infectious Diseases, Federal University of Espirito Santo (UFES), Vitoria 29043900, Brazil. FAU - Goncalves, Sarah Santos AU - Goncalves SS AUID- ORCID: 0000-0003-4170-4445 AD - Department of Pathology, Infectious Diseases Postgraduate Program, Center for Research in Medical Mycology, Federal University of Espirito Santo (UFES), Vitoria 29043900, Brazil. LA - eng PT - Journal Article PT - Review DEP - 20221018 PL - Switzerland TA - J Fungi (Basel) JT - Journal of fungi (Basel, Switzerland) JID - 101671827 PMC - PMC9605487 OTO - NOTNLM OT - Paracoccidioides spp. OT - endemic mycosis OT - paracoccidioidomycosis OT - thermodimorphic fungi COIS- The authors declare no conflict of interest. EDAT- 2022/10/28 06:00 MHDA- 2022/10/28 06:01 PMCR- 2022/10/18 CRDT- 2022/10/27 01:32 PHST- 2022/09/01 00:00 [received] PHST- 2022/10/11 00:00 [revised] PHST- 2022/10/14 00:00 [accepted] PHST- 2022/10/27 01:32 [entrez] PHST- 2022/10/28 06:00 [pubmed] PHST- 2022/10/28 06:01 [medline] PHST- 2022/10/18 00:00 [pmc-release] AID - jof8101098 [pii] AID - jof-08-01098 [pii] AID - 10.3390/jof8101098 [doi] PST - epublish SO - J Fungi (Basel). 2022 Oct 18;8(10):1098. doi: 10.3390/jof8101098.